Profile for Soligenix Inc. (SNGX)

$ 1.26   0.02 (+1.61%) Volume: 124.88k 3:59 PM EST Dec 13, 2019
After Hours:  $ 1.28   0.02 (+1.59%) Volume: 8 4:09 PM EST Dec 13, 2019
Business Description:
Soligenix Inc focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Address: 29 Emmons Drive, Suite B-10, Princeton, NJ, USA, 08540
Telephone: +1 609 538-8200 Website: https://www.soligenix.com
Facsimile: +1 609 452-6467 Email: [email protected]
Details
CEO: Christopher J. Schaber
Employees: 14 Market Cap: 26.02m
Issue Type: CS
Auditor: EisnerAmper LLP
Last Audit: Unqualified Opinion
Indices: Biotechnology
Industry Classifications
Sector: Healthcare CIK: 812796
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)